Company Filing History:
1 out of 15 
1 out of 5,076 
1 out of 6 Years Active: 2006-2018
Title: Berangere Avalle-Bihan: Innovator in Cancer Treatment and Antibody Modulation
Introduction
Berangere Avalle-Bihan is a notable inventor based in Compiègne, France. He has made significant contributions to the fields of cancer treatment and antibody modulation. With a total of 2 patents, his work focuses on innovative solutions for complex medical challenges.
Latest Patents
One of his latest patents is titled "STAT5 inhibitors and use thereof." This invention provides a composition of matter that binds specifically to STAT5, particularly STAT5B. It includes a nucleic acid aptamer and outlines methods for treating cancer, especially leukemia, through the inhibition of the STAT5 protein. The invention also details a method for detecting STAT5 in biological samples by using a nucleic acid aptamer that binds specifically to STAT5.
Another significant patent involves "Compounds capable of modulating the activity and stimulating the production of a catalytic antibody." This invention introduces novel compounds that can enhance the activity of antibodies with specific affinity for their catalytic sites. These compounds are non-immunogenic and are particularly useful for therapeutic treatments related to enzymatic deficiencies, as well as for stimulating the in vivo hydrolysis of potentially toxic molecules.
Career Highlights
Berangere Avalle-Bihan has worked with esteemed institutions such as the Université de Technologie de Compiègne and the Centre National de la Recherche Scientifique. His research has contributed to advancements in medical science, particularly in the areas of cancer and immunology.
Collaborations
He has collaborated with notable colleagues, including Alain Friboulet and Claire Loussouarn, who have contributed to his research endeavors.
Conclusion
Berangere Avalle-Bihan's innovative work in the development of STAT5 inhibitors and antibody modulation showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in treating cancer and related diseases.